Olivier Cussenot
Overview
Explore the profile of Olivier Cussenot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
317
Citations
8328
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Koutros S, Kiemeney L, Pal Choudhury P, Milne R, Lopez de Maturana E, Ye Y, et al.
Eur Urol
. 2023 May;
84(1):127-137.
PMID: 37210288
Background: Genomic regions identified by genome-wide association studies (GWAS) for bladder cancer risk provide new insights into etiology. Objective: To identify new susceptibility variants for bladder cancer in a meta-analysis...
22.
Hess T, Maj C, Gehlen J, Borisov O, Haas S, Gockel I, et al.
EBioMedicine
. 2023 May;
92:104616.
PMID: 37209533
Background: Gastric cancer (GC) is clinically heterogenous according to location (cardia/non-cardia) and histopathology (diffuse/intestinal). We aimed to characterize the genetic risk architecture of GC according to its subtypes. Another aim...
23.
Lejeune C, Bourredjem A, Binquet C, Cussenot O, Boudrant G, Papillon F, et al.
World J Urol
. 2023 May;
41(6):1541-1549.
PMID: 37173454
Purpose: In diseases where there is no real consensus regarding treatment modalities, promoting shared decision-making can contribute to improving safety and quality of care. This is the case in low-...
24.
Srinivasan S, Kryza T, Bock N, Tse B, Sokolowski K, Panchadsaram J, et al.
Res Sq
. 2023 Apr;
PMID: 37034758
Genetic variation at the 19q13.3 locus is linked with prostate cancer susceptibility. The non-synonymous SNP, rs17632542 (c.536T>C; Ile163Thr-substitution in PSA) is associated with reduced prostate cancer risk, however, the functional...
25.
Chen F, Madduri R, Rodriguez A, Darst B, Chou A, Sheng X, et al.
Eur Urol
. 2023 Mar;
84(1):13-21.
PMID: 36872133
Background: Genetic factors play an important role in prostate cancer (PCa) susceptibility. Objective: To discover common genetic variants contributing to the risk of PCa in men of African ancestry. Design,...
26.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2023 Feb;
83(5):e140-e141.
PMID: 36841687
No abstract available.
27.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Oncol
. 2023 Jan;
6(2):214-221.
PMID: 36670042
Background: Ta grade 3 (G3) non-muscle-invasive bladder cancer (NMIBC) is a relatively rare diagnosis with an ambiguous character owing to the presence of an aggressive G3 component together with the...
28.
Cussenot O, Renard-Penna R, Montagne S, Ondet V, Pilon A, Guechot J, et al.
BJU Int
. 2023 Jan;
131(6):745-754.
PMID: 36648168
Objectives: To evaluate different scenarios for the management of early diagnosis of cancer (PCa) in men at high genetic risk, using recently developed blood and urinary molecular biomarkers in combination...
29.
Derrien A, Houy A, Ganier O, Dingli F, Ningarhari M, Mobuchon L, et al.
Am J Hum Genet
. 2022 Dec;
109(12):2196-2209.
PMID: 36459980
The TERT/CLPTM1L risk locus on chromosome 5p15.33 is a pleiotropic cancer risk locus in which multiple independent risk alleles have been identified, across well over ten cancer types. We previously...
30.
Cussenot O, Cancel-Tassin G, Comperat E, Benbouzid S, Lamb A
BJU Int
. 2022 Oct;
130(5):582-585.
PMID: 36263588
No abstract available.